Fiasp(R) Significantly Improved Overall Blood Sugar Control in Type 1 Diabetes Long-term
LISBON, Portugal, Sept. 12, 2017 /PRNewswire/ — Fiasp® (fast-acting insulin aspart), the only approved, new-generation, ultra-fast acting– mealtime insulin, improved overall blood sugar (HbA1c) and post-meal sugar (postprandial glucose or…